Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.

González-Salvatierra S, García-Fontana B, García-Fontana C, Martínez-Heredia L, Rojas-Pérez JF, Andreo-López MC, García-Martín A, Muñoz-Torres M

Open source

DOI
10.3390/ijms27167503
Published
2026 Aug 21
Container
International journal of molecular sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27167503,
  title = {Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.},
  author = {González-Salvatierra S and García-Fontana B and García-Fontana C and Martínez-Heredia L and Rojas-Pérez JF and Andreo-López MC and García-Martín A and Muñoz-Torres M},
  year = {2026},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms27167503},
  url = {https://doi.org/10.3390/ijms27167503}
}

RIS

TY  - JOUR
TI  - Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.
AU  - González-Salvatierra S
AU  - García-Fontana B
AU  - García-Fontana C
AU  - Martínez-Heredia L
AU  - Rojas-Pérez JF
AU  - Andreo-López MC
AU  - García-Martín A
AU  - Muñoz-Torres M
PY  - 2026
JO  - International journal of molecular sciences
DO  - 10.3390/ijms27167503
UR  - https://doi.org/10.3390/ijms27167503
ER  - 

APA

S, G., B, G., C, G., L, M., JF, R., MC, A., A, G., & M, M. (2026). Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.. International journal of molecular sciences. https://doi.org/10.3390/ijms27167503

Source records